29 results on '"S.G. Swisher"'
Search Results
2. OA13.06 Surgical Outcomes Following Neoadjuvant Nivolumab or Nivolumab Plus Ipilimumab in Non-Small Cell Lung Cancer - NEOSTAR Study
3. Immune and Circulating Tumor DNA Profiling After Radiation Treatment for Oligometastatic Non-Small Cell Lung Cancer: Translational Correlatives from a Mature Randomized Phase II Trial
4. MA19.03 Differences in Symptom Burden Between Responsive and Progressive Disease in Advanced Non-Small Cell Lung Cancer (aNSCLC)
5. P1.16-31 Body Mass Index Relating to Patient-Reported Symptoms in First-Line Treatment of Metastatic Non-Small Cell Lung Cancer
6. P2.04-90 Nodal Immune Flare (NIF) Following Neoadjuvant Anti-PD-1 and Anti-CTLA-4 Therapy in Non-Small Cell Lung Cancer
7. MA14.10 Clinical Outcomes in Metastatic Squamous Lung Cancer with Targetable Driver Alterations
8. OA03.05 Characterization of the Immunologic Intra-Tumor Heterogeneity in Early Stages of Non-Small Cell Lung Cancer by Multiplex Immunofluorescence
9. P3.01-109 Real-World Patient-Reported Outcome Assessment of Patients with Metastatic Non-Small Cell Lung Cancer
10. Improved Overall Survival with Local Consolidative Therapy in Oligometastatic Non-Small Cell Lung Cancer: Results from a Cohort of 194 Patients with Synchronous Disease
11. P3.09-27 Histopathologic Parameters Define Features of Treatment Response to Neoadjuvant Chemotherapy in Non-Small Cell Lung Cancer
12. MA23.02 Circulating Tumor DNA Analysis with a Novel Variant Classifier for Recurrence Detection in Resected, Early-Stage Lung Cancer
13. P1.04-08 Co-Residence of Patient-Derived Immune Cells in Patient-Derived Xenografts from Lung Cancer Patients
14. Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up
15. P2.04-014 Computing the Impact of Immunotherapy on NSCLC Landscape: The Advanced Non-Small Cell Lung Cancer Holistic Registry (ANCHoR)
16. RAD50 Expression Is Associated with Poor Clinical Outcomes after Radiotherapy in Resected Non–Small Cell Lung Cancer
17. A Prospective Analysis of Factors Affecting Successful Clinical Trial Enrollment and Randomization in the Context of a Randomized Study of Aggressive Local Therapy in Oligometastatic Non-Small Cell Lung Cancer
18. Validation of the 12-Gene Predictive Signature for Adjuvant Chemotherapy Response in Lung Cancer
19. Tumor-Infiltrating Lymphocytes and Overall Survival in Surgically Resected Stage II and III Non–Small Cell Lung Cancer
20. RAD50 Expression Predicts for Locoregional Failure and Distant Metastatic Recurrence After Postoperative Radiation Therapy in Resected Non-Small Cell Lung Cancer
21. Validation of a proliferation-based expression signature as prognostic marker in early stage lung adenocarcinoma
22. Risk factors for local and regional recurrence in patients with resected N0-N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy
23. The Influence of Positron Emission Tomography Scanning on Delay in Treatment of Non-Small Cell Lung Cancer
24. OC-0496 RISK FACTORS FOR LOCAL AND REGIONAL RECURRENCE IN PATIENTS WITH RESECTED N0-N1 NON-SMALL CELL LUNG CANCER
25. OC-0499 PROGNOSTIC IMPACT OF RADIATION THERAPY TO THE PRIMARY TUMOR IN PATIENTS WITH OLIGOMETASTATIC LUNG CANCER
26. Adenovirus-mediated p53 gene transfer in sequence with cisplatin to tumors of patients with non-small-cell lung cancer
27. Biologic risk model for recurrence in resected early-stage non-small cell lung cancer (ES NSCLC)
28. Gene replacement for lung cancer
29. Gene therapy strategies for lung cancer
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.